Dergiler / Astım Allerji İmmünoloji / 2021 / Cilt: 19 - Sayı: 1

Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria

Sayfa
6–11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A psychological pre-assessment and psychiatricconsultation in necessary cases could make a significant improvement in the management of CU.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Chronic urticaria (CU), a common disease characterized by itching wheals, leads to a negative effect of on quality of life(QoL).
📊
Temel Bulgular & Veri:We aimed to i) evaluate depression, anxiety levels and QoLin patients with CU and compare these with those of controls, ii) show whether there is any correlation between disease activity andQoL, anxiety, and depression.Materials and Methods: A total of 105 CU patients and 86 controls, all above the age of 18 years, were included.
💡
Sonuç & Katkı:A psychological pre-assessment and psychiatricconsultation in necessary cases could make a significant improvement in the management of CU.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Chronic urticaria (CU), a common disease characterized by itching wheals, leads to a negative effect of on quality of life(QoL). It may cause anxiety and depression or result in exacerbation of these. We aimed to i) evaluate depression, anxiety levels and QoLin patients with CU and compare these with those of controls, ii) show whether there is any correlation between disease activity andQoL, anxiety, and depression.Materials and Methods: A total of 105 CU patients and 86 controls, all above the age of 18 years, were included. Levels of anxiety,depression, and disease activity in patients and controls were measured with the Spielberger State/Trait Anxiety Inventory (STAI-S/T),Beck Depression Inventory (BDI), and Urticaria Activity Score 7 (UAS7). QoL was evaluated with the Dermatology Life Quality Index(DQLI) for CU patients. Data were analyzed with SPSS 24.0. A p-value of less than 0.05 was considered statistically significant.Results: STAI-S showed that the anxiety rate was nearly two-fold in patients with CU compared to the controls (63.4% vs. 35.1%,p=0.001). When BDI scores were categorized, a higher fraction of controls had minimal BDI scores, compared to the patients who hadmoderate to severe depression (75.2% vs. 39%, p=0.0001). A positive, but low-to-moderate correlation was determined between diseaseactivity and impaired QoL (R: 0.448, p: 0.001).Conclusion: Anxiety and depression levels were higher in CU patients. DQLI was low-to-moderately correlated with disease activity;patients with higher disease activity had higher levels of impairment in the quality of life. A psychological pre-assessment and psychiatricconsultation in necessary cases could make a significant improvement in the management of CU.

🔖

Bu Makaleye Atıf Yap

EMRE, E., TAZEGÜL, G. (2021). Evaluation of Anxiety, Depression and Quality of Life in Patients with Chronic Urticaria. Astım Allerji İmmünoloji, Cilt: 19 - Sayı: 1, 6–11. https://ajindex.com/articles/351199

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Saini SS. Urticaria and angioedema. Urticaria and angioedema In: Adkinson Jr N, Bochner B, Burks AW, Busse W, Holgate S, Lemanske R, O’Hehir R (eds), Middleton’s Allergy. Princ Pract, 8th ed., vol. 1–2, Elsevier Inc; 2014:575-87
  2. Bansal CJ, Bansal AS. Stress, pseudoallergens, autoimmunity, infection and inflammation in chronic spontaneous urticaria. Allergy Asthma Clin Immunol 2019;15:56
  3. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy Eur J Allergy Clin Immunol 2018;73:1393-414
  4. Staubach P, Dechene M, Metz M, Magerl M, Siebenhaar F, Weller K, et al. High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol 2011;91:557-61
  5. Gupta M, Gupta A. The use of antidepressant drugs in dermatology. J Eur Acad Dermatology Venereol 2001;15:512-8
  6. Hashiro M. Psychosomatic treatment of a case of chronic urticaria. J Dermatol 1995;22:686-9
  7. Gupta MA, Gupta AK. Chronic idiopathic urticaria and posttraumatic stress disorder (PTSD): An under-recognized comorbidity. Clin Dermatol 2012;30:351-4
  8. Engin B, Uguz F, Yilmaz E, Özdemir M, Mevlitoglu I. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatology Venereol 2008;22:36-40
  9. Hisli N. Beck Depresyon Envanterinin gecerliligi uzerine bir calisma (A study on the validity of Beck Depression Inventory). Psikol Dergisi 1988;6:118-22
  10. Beck AT, Steer RA, Brown GK. Beck depression inventory-II. San Antonio 1996;78:490-8
  11. Oner N, LeCompte WA. Durumluk-sürekli kaygı envanteri el kitabı. İstanbul: Boğaziçi Üniversitesi Yayınları, 1985
  12. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 2011;63:S467-72
  13. Öztürkcan S, Ermertcan AT, Eser E, Turhan Şahin M. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol 2006;45:1300-7
  14. Hongbo Y, Thomas CL, Harrison MA, Sam Salek M, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005;125:659-64
  15. Annesi-Maesano I, Beyer A, Marmouz F, Mathelier-Fusade P, Vervloet D, Bauchau V. Do patients with skin allergies have